Addressing vaccine hesitancy in developing countries: Survey and experimental evidence

    Research output: Contribution to journalArticle


    Vaccine hesitancy is proving to be a significant impediment to COVID-19 vaccination campaigns in some developing countries. This study focuses on vaccine hesitancy and means of reducing it. Data come from a large, representative phone survey and online randomized survey experiment, both run in Papua New Guinea, a developing country with low vaccination rates. Less than 20% of relevant respondents to the phone survey were willing to be vaccinated, primarily because of fear of side effects and low trust in the vaccine. Although vaccine hesitancy was high in the online experiment, participants who received a message emphasizing that the vaccine was safe and COVID-19 dangerous were 68% more likely to state they planned to be vaccinated than those in the control group. A message appealing to social norms was also effective in reducing vaccine hesitancy, although its efficacy was limited to certain types of people.
    Original languageEnglish
    JournalPLOS ONE (Public Library of Science)
    Issue numberONLINE
    Publication statusPublished - 2022


    Dive into the research topics of 'Addressing vaccine hesitancy in developing countries: Survey and experimental evidence'. Together they form a unique fingerprint.

    Cite this